{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:11:20Z","timestamp":1786119080218,"version":"build-2736575974"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>The past decade has seen substantial progress in defining the cause and pathogenesis of the chronic childhood arthropathy systemic juvenile idiopathic arthritis (SJIA) and its related complication macrophage activation syndrome (MAS). The purpose of this review is to describe and synthesize advances in this field, particularly since 2016, with the potential to transform clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Newly developed MAS classification criteria have been further studied and validated in other diseases and populations, as well as a recently proposed score to distinguish MAS from familial hemophagocytic lymphohistiocytosis. There has also been substantial progress toward understanding the genetic underpinnings of SJIA and MAS, both through targeted study of specific genes and the results of a large genome-wide association study. The immunopathogenesis of SJIA has been further elucidated through several studies regarding the proinflammatory cytokines interleukin-18, interferon (IFN)\u03b3, and how their interplay impacts emergence of MAS. Finally, big data studies integrating genomic information with immunophenotypes have potential to provide novel insights into disease mechanisms in SJIA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Collectively, these research advances have significant implications regarding the classification and diagnosis of SJIA and MAS, and support a next generation of biologic treatments including kinase inhibitors and targeted interleukin-18 or IFN\u03b3 blockade.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000000526","type":"journal-article","created":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T16:12:56Z","timestamp":1528215176000},"page":"514-520","source":"Crossref","is-referenced-by-count":54,"title":["Systemic juvenile idiopathic arthritis and macrophage activation syndrome: update on pathogenesis and treatment"],"prefix":"10.1097","volume":"30","author":[{"given":"Shima","family":"Yasin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant S.","family":"Schulert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230829","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"R2-20230829","doi-asserted-by":"crossref","first-page":"15785","DOI":"10.1073\/pnas.1521837113","article-title":"Autoinflammation and autoimmunity in systemic juvenile idiopathic arthritis","volume":"112","author":"Nigrovic","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"R3-20230829","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nrrheum.2011.68","article-title":"Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions","volume":"7","author":"Mellins","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"R4-20230829","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-med-061813-012806","article-title":"Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies","volume":"66","author":"Schulert","year":"2015","journal-title":"Annu Rev Med"},{"key":"R5-20230829","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/ACI.0b013e32834c22f5","article-title":"The expanding spectrum of hemophagocytic lymphohistiocytosis","volume":"11","author":"Filipovich","year":"2011","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R6-20230829","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrrheum.2015.179","article-title":"Macrophage activation syndrome in the era of biologic therapy","volume":"12","author":"Grom","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"R7-20230829","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/art.39332","article-title":"2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: a European League Against Rheumatism\/American College of Rheumatology\/Paediatric Rheumatology International Trials Organisation Collaborat","volume":"68","author":"Ravelli","year":"2016","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"R8-20230829","article-title":"Validation of classification criteria of macrophage activation syndrome in Japanese patients with systemic juvenile idiopathic arthritis","author":"Shimizu","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R9-20230829","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3899\/jrheum.161286","article-title":"Application of the 2016\u200aEULAR\/ACR\/PRINTO Classification Criteria for Macrophage Activation Syndrome in Patients with Adult-onset Still Disease","volume":"44","author":"Ahn","year":"2017","journal-title":"J Rheumatol"},{"key":"R10-20230829","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jpeds.2017.06.005","article-title":"Development and Initial Validation of the Macrophage Activation Syndrome\/Primary Hemophagocytic Lymphohistiocytosis Score, a diagnostic tool that differentiates primary hemophagocytic lymphohistiocytosis from macrophage activation syndrome","volume":"189","author":"Minoia","year":"2017","journal-title":"J Pediatr"},{"key":"R11-20230829","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/03009742.2016.1167951","article-title":"Assessment of the HScore for reactive haemophagocytic syndrome in patients with rheumatic diseases","volume":"46","author":"Batu","year":"2017","journal-title":"Scand J Rheumatol"},{"key":"R12-20230829","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"R13-20230829","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.cyto.2012.02.006","article-title":"Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6","volume":"58","author":"Shimizu","year":"2012","journal-title":"Cytokine"},{"key":"R14-20230829","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/acr.23277","article-title":"Effect of biologic therapy on clinical and laboratory features of macrophage activation syndrome associated with systemic juvenile idiopathic arthritis","volume":"70","author":"Schulert","year":"2018","journal-title":"Arthritis Care Res"},{"key":"R15-20230829","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/rheumatology\/40.11.1285","article-title":"Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients","volume":"40","author":"Stephan","year":"2001","journal-title":"Rheumatol"},{"key":"R16-20230829","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/art.40417","article-title":"Features, treatment, and outcomes of macrophage activation syndrome in childhood-onset systemic lupus erythematosus","volume":"70","author":"Borgia","year":"2018","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"R17-20230829","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s10067-017-3625-6","article-title":"Macrophage activation syndrome in systemic lupus erythematosus: a multicenter, case-control study in China","volume":"37","author":"Liu","year":"2018","journal-title":"Clin Rheumatol"},{"key":"R18-20230829","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.semarthrit.2017.02.002","article-title":"In-hospital mortality in febrile lupus patients based on 2016\u200aEULAR\/ACR\/PRINTO classification criteria for macrophage activation syndrome","volume":"47","author":"Ahn","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"R19-20230829","doi-asserted-by":"crossref","first-page":"15970","DOI":"10.1073\/pnas.1520779112","article-title":"HLA-DRB1\u221711 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis","volume":"112","author":"Ombrello","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"R20-20230829","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1136\/annrheumdis-2016-210324","article-title":"Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications","volume":"76","author":"Ombrello","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R21-20230829","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.40350","article-title":"Review: genetics and the classification of arthritis in adults and children","volume":"70","author":"Nigrovic","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"R22-20230829","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/art.38877","article-title":"Association of a mutation in lacc1 with a monogenic form of systemic juvenile idiopathic arthritis","volume":"67","author":"Wakil","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R23-20230829","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12969-016-0124-2","article-title":"Juvenile arthritis caused by a novel FAMIN (LACC1) mutation in two children with systemic and extended oligoarticular course","volume":"14","author":"Kallinich","year":"2016","journal-title":"Pediatr Rheumatol"},{"key":"R24-20230829","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/gene.2016.17","article-title":"LACC1 polymorphisms in inflammatory bowel disease and juvenile idiopathic arthritis","volume":"17","author":"Assadi","year":"2016","journal-title":"Genes Immun"},{"key":"R25-20230829","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/ni.3532","article-title":"C13orf31 (FAMIN) is a central regulator of immunometabolic function","volume":"17","author":"Cader","year":"2016","journal-title":"Nat Immunol"},{"key":"R26-20230829","doi-asserted-by":"crossref","first-page":"15614","DOI":"10.1038\/ncomms15614","article-title":"Human LACC1 increases innate receptor-induced responses and a LACC1 disease-risk variant modulates these outcomes","volume":"8","author":"Lahiri","year":"2017","journal-title":"Nat Commun"},{"key":"R27-20230829","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/rheumatology\/kep418","article-title":"Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis","volume":"49","author":"Vastert","year":"2010","journal-title":"Rheumatol"},{"key":"R28-20230829","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1002\/art.38793","article-title":"Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis","volume":"66","author":"Kaufman","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"R29-20230829","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s11926-014-0439-2","article-title":"Genetic defects in cytolysis in macrophage activation syndrome","volume":"16","author":"Zhang","year":"2014","journal-title":"Curr Rheumatol Rep"},{"key":"R30-20230829","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1546-0096-12-S1-P53","article-title":"Mutations of familial hemophagocytic lymphohistiocytosis (FHL) related genes and abnormalities of cytotoxicity function tests in patients with macrophage activation syndrome (MAS) occuring in systemic juvenile idiopathic arthritis (sJIA)","volume":"12","author":"Bracaglia","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"key":"R31-20230829","doi-asserted-by":"crossref","DOI":"10.1002\/art.40438","article-title":"Novel UNC13D intronic variant disrupting a NF(B enhancer in a patient with recurrent macrophage activation syndrome and systemic juvenile idiopathic arthritis","author":"Schulert","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"R32-20230829","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/infdis\/jiv550","article-title":"Whole-exome sequencing reveals mutations in genes linked to hemophagocytic lymphohistiocytosis and macrophage activation syndrome in fatal cases of H1N1 influenza","volume":"213","author":"Schulert","year":"2016","journal-title":"J Infect Dis"},{"key":"R33-20230829","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.4049\/jimmunol.1501284","article-title":"A heterozygous RAB27A mutation associated with delayed cytolytic granule polarization and hemophagocytic lymphohistiocytosis","volume":"196","author":"Zhang","year":"2016","journal-title":"J Immunol"},{"key":"R34-20230829","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/ng.3089","article-title":"An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome","volume":"46","author":"Canna","year":"2014","journal-title":"Nat Genet"},{"key":"R35-20230829","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/ng.3066","article-title":"Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation","volume":"46","author":"Romberg","year":"2014","journal-title":"Nat Genet"},{"key":"R36-20230829","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13075-016-1212-x","article-title":"Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapy","volume":"19","author":"Brachat","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"R37-20230829","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1182\/blood-2017-12-820852","article-title":"Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome","volume":"131","author":"Weiss","year":"2018","journal-title":"Blood"},{"key":"R38-20230829","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1182\/blood-2017-06-789552","article-title":"Unopposed IL-18 signaling leads to severe TLR9-induced macrophage activation syndrome in mice","volume":"131","author":"Girard-Guyonvarc\u2019h","year":"2018","journal-title":"Blood"},{"key":"R39-20230829","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.jaci.2016.10.022","article-title":"Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition","volume":"139","author":"Canna","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"R40-20230829","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/annrheumdis-2017-212608","article-title":"Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease","volume":"77","author":"Gabay","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R41-20230829","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/art.40099","article-title":"Proinflammatory cytokine environments can drive interleukin-17 overexpression by (\u03b3\/\u03b4 T cells in systemic juvenile idiopathic arthritis","volume":"69","author":"Kessel","year":"2017","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"R42-20230829","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/rheumatology\/keu524","article-title":"Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-\u03b3","volume":"54","author":"Put","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"R43-20230829","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood-2004-08-2997","article-title":"Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages","volume":"105","author":"Billiau","year":"2005","journal-title":"Blood"},{"key":"R44-20230829","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/annrheumdis-2015-209020","article-title":"Elevated circulating levels of interferon-\u03b3 and interferon\u03b3-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"76","author":"Bracaglia","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R45-20230829","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jaci.2017.07.021","article-title":"Neutralization of IFN-\u03b3 reverts clinical and laboratory features in a mouse model of macrophage activation syndrome","volume":"141","author":"Prencipe","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"R46-20230829","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/art.24750","article-title":"Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis","volume":"60","author":"de Jager","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R47-20230829","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/art.39933","article-title":"Inflammatory gene expression profile and defective interferon-\u03b3 and granzyme K in natural killer cells from systemic juvenile idiopathic arthritis patients","volume":"69","author":"Put","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R48-20230829","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1084\/jem.20170412","article-title":"A multidimensional blood stimulation assay reveals immune alterations underlying systemic juvenile idiopathic arthritis","volume":"214","author":"Cepika","year":"2017","journal-title":"J Exp Med"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002281-201809000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:27:55Z","timestamp":1786037275000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002281-201809000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000526","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}